Sign in

CIK 0001636282 · Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464312787
Phone
6176515940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 8-K Event Shareholder vote results
  5. UPLOAD Other SEC-generated Letter
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. 8-K Event Results of operations
  9. 10-Q Report Quarterly Report
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. EFFECT Other Notice of Effectiveness
  15. EFFECT Other Notice of Effectiveness
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. 8-K Event Auditor change
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. S-3 Offering Registration Statement

Page 7 of 42 · 823 filings